AG
Congress trade
Rep. Andrew Garbarino (R-NY) sold $1K-$15K of Oramed Pharmaceuticals Inc. (ORMP) stock
Andrew Garbarino, U.S. Representative (R-NY), disclosed a sale of Oramed Pharmaceuticals Inc. (ORMP) stock worth $1K-$15K in a STOCK Act filing on Jan 14, 2022.
The trade was disclosed on Jan 14, 2022.
ORMP has moved -57.2% since the trade date, from $11.05 to $4.73 (Sep 25, 2026 close).
- Traded
- Jan 14, 2022
- Disclosed
- Jan 14, 2022
- Filing delay
- 0 days
- Price since
- -57.2%
- Source
- STOCK Act disclosure
Other trades in this disclosure (1)
More ORMP insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.